Browse by category

Researchers at Oregon State University (OSU) have invented a new analytical method that sheds light on an enduring mystery regarding type...

New data from Fractyl Health’s Revita-1 and Revita-2 studies presented at Digestive Disease Week 2022 builds on this earlier evidence to...

Two studies have reported that reproductive hormone levels in females with obesity may be partially restored by lowering blood glucose...

Canadian and German researchers are teaming up to identify new drug combinations to treat people with obesity and type 2 diabetes. The...

The FDA has approved Mounjaro (tirzepatide, Eli Lilly and Company) injection to improve blood sugar control in adults with type 2...

Having a long-term commitment for participants in primary healthcare interventions could be beneficial for the reduction of diabetes risk...

Results from the Diabetes UK-funded Reversal of Type 2 Diabetes upon Normalisation of Energy Intake in the Non-obese (ReTUNE) trial, have...

German researchers have noted a possible association between mild COVID-19 cases and subsequently diagnosing type 2 diabetes. The...

Roux-en-Y gastric bypass (RYGB) leads to greater weight loss and a greater rate of remission of diabetes than sleeve gastrectomy or...

Roux-en-Y gastric bypass (RYGB) is more efficient (excess weight loss, EWL percentage) than sleeve gastrectomy (SG) after five years,...